Stocks and Investing
Stocks and Investing
Thu, September 7, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, September 6, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Morten Herholdt Initiated (ATNM) at Strong Buy and Held Target at $12 on, Sep 6th, 2023
Morten Herholdt of HSBC, Initiated "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy and Held Target at $12 on, Sep 6th, 2023.
Morten has made no other calls on ATNM in the last 4 months.
There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, 0 agree with Morten's Rating of Hold.
This is the rating of the analyst that currently disagrees with Morten
- Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $50 on, Tuesday, August 15th, 2023
Contributing Sources